PUMA BIOTECHNOLOGY INC shareholders Q2 2024

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 100 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2024. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

PUMA BIOTECHNOLOGY INC shareholders Q2 2024
NameSharesValueWeighting ↓
Concord Wealth Partners 6$200.00%
WELLS FARGO & COMPANY/MN 16,450$53,6270.00%
GEODE CAPITAL MANAGEMENT, LLC 950,146$3,097,8270.00%
BANK OF AMERICA CORP /DE/ 30,120$98,1910.00%
US BANCORP \DE\ 200$6520.00%
Corebridge Financial, Inc. 22,269$72,8200.00%
FMR LLC 93,082$303,4470.00%
COMMONWEALTH EQUITY SERVICES, LLC 10,790$350.00%
BARCLAYS PLC 31,651$1040.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 2,999$9,7770.00%
VOYA INVESTMENT MANAGEMENT LLC 15,603$50,8660.00%
CIBC Private Wealth Group LLC 775$2,3100.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 17,765$57,9140.00%
Ameritas Investment Partners, Inc. 4,055$13,2190.00%
BlackRock Inc. 3,572,806$11,647,3470.00%
Bank of New York Mellon Corp 308,997$1,007,3300.00%
GHP Investment Advisors, Inc. 1,170$3,8150.00%
LPL Financial LLC 20,677$67,4070.00%
MACQUARIE GROUP LTD 61,255$200,0000.00%
Citadel Advisors 3,300$10,7580.00%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q2 2024. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.